Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 9 |
GO:0110165 | cellular anatomical entity | 1 | 9 |
GO:0005783 | endoplasmic reticulum | 5 | 1 |
GO:0032991 | protein-containing complex | 1 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
GO:0070765 | gamma-secretase complex | 3 | 1 |
GO:0098796 | membrane protein complex | 2 | 1 |
GO:0098797 | plasma membrane protein complex | 3 | 1 |
GO:1902494 | catalytic complex | 2 | 1 |
Related structures:
AlphaFold database: A0A3S7WRT9
Term | Name | Level | Count |
---|---|---|---|
GO:0006508 | proteolysis | 4 | 9 |
GO:0006807 | nitrogen compound metabolic process | 2 | 9 |
GO:0008152 | metabolic process | 1 | 9 |
GO:0016485 | protein processing | 5 | 9 |
GO:0019538 | protein metabolic process | 3 | 9 |
GO:0043085 | positive regulation of catalytic activity | 4 | 9 |
GO:0043170 | macromolecule metabolic process | 3 | 9 |
GO:0044093 | positive regulation of molecular function | 3 | 9 |
GO:0044238 | primary metabolic process | 2 | 9 |
GO:0050790 | regulation of catalytic activity | 3 | 9 |
GO:0051604 | protein maturation | 4 | 9 |
GO:0065007 | biological regulation | 1 | 9 |
GO:0065009 | regulation of molecular function | 2 | 9 |
GO:0071704 | organic substance metabolic process | 2 | 9 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0030674 | protein-macromolecule adaptor activity | 2 | 1 |
GO:0060090 | molecular adaptor activity | 1 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 148 | 150 | PF00675 | 0.570 |
CLV_NRD_NRD_1 | 286 | 288 | PF00675 | 0.523 |
CLV_NRD_NRD_1 | 337 | 339 | PF00675 | 0.441 |
CLV_NRD_NRD_1 | 415 | 417 | PF00675 | 0.601 |
CLV_PCSK_KEX2_1 | 148 | 150 | PF00082 | 0.570 |
CLV_PCSK_KEX2_1 | 286 | 288 | PF00082 | 0.523 |
CLV_PCSK_KEX2_1 | 415 | 417 | PF00082 | 0.601 |
CLV_PCSK_SKI1_1 | 142 | 146 | PF00082 | 0.590 |
DEG_APCC_DBOX_1 | 106 | 114 | PF00400 | 0.520 |
DOC_CYCLIN_yCln2_LP_2 | 26 | 32 | PF00134 | 0.431 |
DOC_MAPK_MEF2A_6 | 105 | 113 | PF00069 | 0.520 |
DOC_MAPK_MEF2A_6 | 82 | 90 | PF00069 | 0.521 |
DOC_PP1_RVXF_1 | 158 | 164 | PF00149 | 0.321 |
DOC_PP1_RVXF_1 | 92 | 98 | PF00149 | 0.582 |
DOC_PP2B_LxvP_1 | 13 | 16 | PF13499 | 0.384 |
DOC_USP7_MATH_1 | 122 | 126 | PF00917 | 0.365 |
DOC_USP7_MATH_1 | 251 | 255 | PF00917 | 0.693 |
DOC_USP7_MATH_1 | 281 | 285 | PF00917 | 0.679 |
DOC_USP7_MATH_1 | 302 | 306 | PF00917 | 0.696 |
DOC_USP7_MATH_1 | 330 | 334 | PF00917 | 0.735 |
DOC_USP7_MATH_1 | 353 | 357 | PF00917 | 0.649 |
DOC_USP7_MATH_1 | 399 | 403 | PF00917 | 0.411 |
DOC_USP7_MATH_1 | 409 | 413 | PF00917 | 0.471 |
DOC_USP7_MATH_1 | 414 | 418 | PF00917 | 0.423 |
DOC_WW_Pin1_4 | 349 | 354 | PF00397 | 0.693 |
DOC_WW_Pin1_4 | 407 | 412 | PF00397 | 0.350 |
LIG_14-3-3_CanoR_1 | 148 | 156 | PF00244 | 0.476 |
LIG_14-3-3_CanoR_1 | 175 | 185 | PF00244 | 0.348 |
LIG_14-3-3_CanoR_1 | 307 | 315 | PF00244 | 0.666 |
LIG_14-3-3_CanoR_1 | 338 | 345 | PF00244 | 0.713 |
LIG_14-3-3_CanoR_1 | 415 | 422 | PF00244 | 0.421 |
LIG_14-3-3_CanoR_1 | 446 | 452 | PF00244 | 0.633 |
LIG_Actin_WH2_2 | 41 | 59 | PF00022 | 0.364 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.540 |
LIG_FHA_1 | 224 | 230 | PF00498 | 0.795 |
LIG_FHA_1 | 257 | 263 | PF00498 | 0.693 |
LIG_FHA_1 | 3 | 9 | PF00498 | 0.488 |
LIG_FHA_1 | 448 | 454 | PF00498 | 0.637 |
LIG_FHA_1 | 47 | 53 | PF00498 | 0.344 |
LIG_FHA_1 | 66 | 72 | PF00498 | 0.417 |
LIG_FHA_1 | 83 | 89 | PF00498 | 0.515 |
LIG_LIR_Gen_1 | 2 | 10 | PF02991 | 0.600 |
LIG_LIR_Gen_1 | 39 | 48 | PF02991 | 0.345 |
LIG_LIR_Gen_1 | 450 | 454 | PF02991 | 0.658 |
LIG_LIR_Gen_1 | 66 | 76 | PF02991 | 0.603 |
LIG_LIR_Nem_3 | 106 | 111 | PF02991 | 0.611 |
LIG_LIR_Nem_3 | 2 | 6 | PF02991 | 0.602 |
LIG_LIR_Nem_3 | 39 | 43 | PF02991 | 0.311 |
LIG_LIR_Nem_3 | 450 | 454 | PF02991 | 0.658 |
LIG_LIR_Nem_3 | 66 | 72 | PF02991 | 0.596 |
LIG_NRBOX | 172 | 178 | PF00104 | 0.436 |
LIG_PCNA_yPIPBox_3 | 416 | 430 | PF02747 | 0.248 |
LIG_Pex14_2 | 181 | 185 | PF04695 | 0.356 |
LIG_SH2_CRK | 3 | 7 | PF00017 | 0.462 |
LIG_SH2_SRC | 14 | 17 | PF00017 | 0.364 |
LIG_SH2_STAP1 | 201 | 205 | PF00017 | 0.344 |
LIG_SH2_STAP1 | 3 | 7 | PF00017 | 0.485 |
LIG_SH2_STAT5 | 314 | 317 | PF00017 | 0.697 |
LIG_SH3_3 | 106 | 112 | PF00018 | 0.536 |
LIG_SH3_3 | 292 | 298 | PF00018 | 0.625 |
LIG_SH3_3 | 388 | 394 | PF00018 | 0.349 |
LIG_Sin3_3 | 381 | 388 | PF02671 | 0.241 |
LIG_SUMO_SIM_anti_2 | 431 | 437 | PF11976 | 0.329 |
LIG_SUMO_SIM_anti_2 | 68 | 74 | PF11976 | 0.424 |
LIG_SUMO_SIM_par_1 | 29 | 35 | PF11976 | 0.329 |
LIG_SUMO_SIM_par_1 | 428 | 434 | PF11976 | 0.285 |
LIG_SUMO_SIM_par_1 | 440 | 445 | PF11976 | 0.486 |
LIG_TRAF2_1 | 265 | 268 | PF00917 | 0.608 |
LIG_TRAF2_1 | 298 | 301 | PF00917 | 0.775 |
LIG_TRFH_1 | 108 | 112 | PF08558 | 0.506 |
LIG_TRFH_1 | 390 | 394 | PF08558 | 0.384 |
LIG_WRC_WIRS_1 | 37 | 42 | PF05994 | 0.341 |
MOD_CK1_1 | 151 | 157 | PF00069 | 0.443 |
MOD_CK1_1 | 2 | 8 | PF00069 | 0.468 |
MOD_CK1_1 | 351 | 357 | PF00069 | 0.691 |
MOD_CK1_1 | 404 | 410 | PF00069 | 0.444 |
MOD_CK2_1 | 251 | 257 | PF00069 | 0.745 |
MOD_CK2_1 | 330 | 336 | PF00069 | 0.768 |
MOD_CK2_1 | 352 | 358 | PF00069 | 0.676 |
MOD_GlcNHglycan | 166 | 169 | PF01048 | 0.637 |
MOD_GlcNHglycan | 241 | 244 | PF01048 | 0.553 |
MOD_GlcNHglycan | 290 | 293 | PF01048 | 0.482 |
MOD_GlcNHglycan | 310 | 313 | PF01048 | 0.511 |
MOD_GlcNHglycan | 316 | 320 | PF01048 | 0.471 |
MOD_GlcNHglycan | 328 | 331 | PF01048 | 0.526 |
MOD_GlcNHglycan | 342 | 345 | PF01048 | 0.467 |
MOD_GlcNHglycan | 355 | 358 | PF01048 | 0.461 |
MOD_GlcNHglycan | 401 | 404 | PF01048 | 0.595 |
MOD_GlcNHglycan | 412 | 415 | PF01048 | 0.626 |
MOD_GSK3_1 | 144 | 151 | PF00069 | 0.503 |
MOD_GSK3_1 | 277 | 284 | PF00069 | 0.759 |
MOD_GSK3_1 | 315 | 322 | PF00069 | 0.586 |
MOD_GSK3_1 | 32 | 39 | PF00069 | 0.406 |
MOD_GSK3_1 | 326 | 333 | PF00069 | 0.764 |
MOD_GSK3_1 | 347 | 354 | PF00069 | 0.774 |
MOD_GSK3_1 | 401 | 408 | PF00069 | 0.466 |
MOD_GSK3_1 | 410 | 417 | PF00069 | 0.508 |
MOD_GSK3_1 | 78 | 85 | PF00069 | 0.550 |
MOD_N-GLC_1 | 422 | 427 | PF02516 | 0.283 |
MOD_N-GLC_1 | 78 | 83 | PF02516 | 0.334 |
MOD_NEK2_1 | 103 | 108 | PF00069 | 0.588 |
MOD_NEK2_1 | 144 | 149 | PF00069 | 0.385 |
MOD_NEK2_1 | 163 | 168 | PF00069 | 0.363 |
MOD_NEK2_1 | 176 | 181 | PF00069 | 0.262 |
MOD_NEK2_1 | 315 | 320 | PF00069 | 0.639 |
MOD_NEK2_1 | 32 | 37 | PF00069 | 0.352 |
MOD_NEK2_1 | 46 | 51 | PF00069 | 0.338 |
MOD_NEK2_2 | 251 | 256 | PF00069 | 0.725 |
MOD_NEK2_2 | 281 | 286 | PF00069 | 0.730 |
MOD_PIKK_1 | 302 | 308 | PF00454 | 0.661 |
MOD_PK_1 | 149 | 155 | PF00069 | 0.352 |
MOD_PKA_1 | 148 | 154 | PF00069 | 0.357 |
MOD_PKA_1 | 338 | 344 | PF00069 | 0.618 |
MOD_PKA_2 | 148 | 154 | PF00069 | 0.498 |
MOD_PKA_2 | 171 | 177 | PF00069 | 0.355 |
MOD_PKA_2 | 414 | 420 | PF00069 | 0.445 |
MOD_Plk_1 | 251 | 257 | PF00069 | 0.761 |
MOD_Plk_1 | 422 | 428 | PF00069 | 0.394 |
MOD_Plk_1 | 78 | 84 | PF00069 | 0.580 |
MOD_Plk_4 | 122 | 128 | PF00069 | 0.312 |
MOD_Plk_4 | 181 | 187 | PF00069 | 0.356 |
MOD_Plk_4 | 32 | 38 | PF00069 | 0.371 |
MOD_Plk_4 | 364 | 370 | PF00069 | 0.561 |
MOD_Plk_4 | 428 | 434 | PF00069 | 0.331 |
MOD_Plk_4 | 65 | 71 | PF00069 | 0.433 |
MOD_ProDKin_1 | 349 | 355 | PF00069 | 0.690 |
MOD_ProDKin_1 | 407 | 413 | PF00069 | 0.348 |
TRG_DiLeu_BaLyEn_6 | 172 | 177 | PF01217 | 0.364 |
TRG_ENDOCYTIC_2 | 201 | 204 | PF00928 | 0.364 |
TRG_ENDOCYTIC_2 | 3 | 6 | PF00928 | 0.462 |
TRG_ENDOCYTIC_2 | 451 | 454 | PF00928 | 0.660 |
TRG_ER_diArg_1 | 104 | 107 | PF00400 | 0.622 |
TRG_ER_diArg_1 | 285 | 287 | PF00400 | 0.728 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HY04 | Leptomonas seymouri | 42% | 95% |
A0A422NUD7 | Trypanosoma rangeli | 29% | 100% |
A4H6T0 | Leishmania braziliensis | 66% | 100% |
A4HV58 | Leishmania infantum | 99% | 100% |
E9ANU1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 83% | 99% |
Q4QGS9 | Leishmania major | 87% | 100% |
V5BDA4 | Trypanosoma cruzi | 24% | 100% |